Immunotherapy for Patients with Follicular Lymphoma: The Contribution of Systematic Reviews

被引：1
|
作者：
Vidal, Liat
Gafter-Gvili, Anat
Shpilberg, Ofer
机构：
[1] Beilinson Med Ctr, Rabin Med Ctr, Inst Hematol, Davidoff Canc Ctr, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
ACTA HAEMATOLOGICA | 2011年 / 125卷 / 1-2期
关键词：
Follicular lymphoma; I-31-tositumomab; Interferon; Rituximab; Y-90-ibritumomab tiuxetan; IBRITUMOMAB TIUXETAN; INFECTIOUS COMPLICATIONS; MAINTENANCE THERAPY; RITUXIMAB; QUALITY; CHEMOTHERAPY; METAANALYSIS; INTERFERON; EFFICACY; TRIAL;
D O I：
10.1159/000318883
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The course of follicular lymphoma has changed considerably with the introduction of immunotherapy. Systematic reviews and meta-analyses are reliable, efficient and well-established methods to summarize the vast amount of data acquired in recent years on the role of immunotherapy, including monoclonal antibodies, radio-labeled monoclonal antibodies and interferon-a in the treatment of patients with follicular lymphoma. We aimed to summarize the data from systematic reviews assessing immunotherapy for these patients. A search through Medline and the Cochrane Library for systematic reviews of randomized controlled trials of different types of immunotherapy for patients with follicular lymphoma yielded 17 reviews. Eleven of them were eligible for this review and are described herein. These systematic reviews have dramatically influenced the approach to patients with follicular lymphoma. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码：23 / 31
页数：9
相关论文
共 50 条
  • [1] Anti-idiotypic immunotherapy in follicular lymphoma patients
    Yanez, Rosa
    Barrios, Yvelise
    Ruiz, Elena
    Cabrera, Rafael
    Diaz-Espada, Fernando
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (03) : 310 - 312
  • [2] Active immunotherapy in follicular lymphoma
    Veelken, H
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 241 - 247
  • [3] REHABILITATION IN PATIENTS WITH LYMPHOMA: AN OVERVIEW OF SYSTEMATIC REVIEWS
    Amatya, Bhasker
    Khan, Fary
    Lew, Thomas E.
    Dickinson, Michael
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2021, 53 (03)
  • [4] Novel immunotherapy approaches to follicular lymphoma
    Flowers, Christopher R.
    Leonard, John P.
    Nastoupil, Loretta J.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 194 - 199
  • [5] Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models
    Li, Yanan
    Zhang, Yan
    Wang, Wei
    Wei, Chong
    Zhao, Danqing
    Zhang, Wei
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1385 - 1393
  • [6] IDENTIFYING EVIDENCE ON THE COST-EFFECTIVENESS OF TREATMENTS AND COSTS/RESOURCE USE AND QUALITY OF LIFE OF PATIENTS WITH FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA: SYSTEMATIC REVIEWS
    Monga, N.
    Garside, J.
    Gurung, B.
    Quigley, J. M.
    O'Donovan, M.
    Padhiar, A.
    Parisi, M.
    Tapprich, C.
    Nastoupil, L.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A556 - A556
  • [7] Systematic reviews of sublingual immunotherapy (SLIT)
    Radulovic, S.
    Wilson, D.
    Calderon, M.
    Durham, S.
    [J]. ALLERGY, 2011, 66 (06) : 740 - 752
  • [8] Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma
    Arzuaga-Mendez, Javier
    Lopez-Santillan, Maria
    Carlos Garcia-Ruiz, Juan
    Lopez-Lopez, Elixabet
    Martin-Guerrero, Idoia
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 159
  • [9] Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
    Stenner, Frank
    Renner, Christoph
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [10] Contribution of Systematic Reviews to Management Decisions
    Cook, Carly N.
    Possingham, Hugh P.
    Fuller, Richard A.
    [J]. CONSERVATION BIOLOGY, 2013, 27 (05) : 902 - 915
12345